​

Krystal Biotech (KRYS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Krystal Biotech Revenue Highlights

Latest Revenue (Y)

$389.13M

Latest Revenue (Q)

$97.80M

Krystal Biotech Revenue by Period

Krystal Biotech Revenue by Year

DateRevenueChange
2025-12-31$389.13M33.94%
2024-12-31$290.51M473.02%
2023-12-31$50.70M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--100.00%
2018-12-31$1.03M100.00%
2017-12-31-100.00%
2016-12-31--

Krystal Biotech generated $389.13M in revenue during NA 2025, up 33.94% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Krystal Biotech Revenue by Quarter

DateRevenueChange
2025-09-30$97.80M1.83%
2025-06-30$96.04M8.91%
2025-03-31$88.18M-3.24%
2024-12-31$91.14M8.70%
2024-09-30$83.84M19.29%
2024-06-30$70.28M55.32%
2024-03-31$45.25M7.37%
2023-12-31$42.14M392.55%
2023-09-30$8.56M100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30--100.00%
2019-06-30$542.00K-7.03%
2019-03-31$583.00K-43.23%
2018-12-31$1.03M373.27%
2018-09-30$217.00K25.43%
2018-06-30$173.00K36.22%
2018-03-31$127.00K100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30--

Krystal Biotech generated $97.80M in revenue during Q3 2025, up 1.83% compared to the previous quarter, and up 139.15% compared to the same period a year ago.

Krystal Biotech Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TFXTeleflex$1.99B$913.02M
PTCTPTC Therapeutics$1.73B$211.01M
ALKSAlkermes$1.48B$394.19M
ARWRArrowhead Pharmaceuticals$829.45M$264.03M
TGTXTG Therapeutics$616.29M$161.71M
KRYSKrystal Biotech$389.13M$97.80M
CRSPCRISPR Therapeutics$3.51M$889.00K
PTGXProtagonist Therapeutics--
PCVXVaxcyte--
MTSRMetsera--
ACLXArcellx-$7.55M

KRYS Revenue FAQ

What is Krystal Biotech’s yearly revenue?

Krystal Biotech's yearly revenue for 2025 was $389.13M, representing an increase of 33.94% compared to 2024. The company's yearly revenue for 2024 was $290.52M, representing an increase of 473.02% compared to 2023. KRYS's yearly revenue for 2023 was $50.7M, representing an increase of 100.00% compared to 2022.

What is Krystal Biotech’s quarterly revenue?

Krystal Biotech's quarterly revenue for Q3 2025 was $97.8M, a 1.83% increase from the previous quarter (Q2 2025), and a 16.65% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $96.04M, a 8.91% increase from the previous quarter (Q1 2025), and a 36.65% increase year-over-year (Q2 2024). KRYS's quarterly revenue for Q1 2025 was $88.18M, a -3.24% decrease from the previous quarter (Q4 2024), and a 94.88% increase year-over-year (Q1 2024).

What is Krystal Biotech’s revenue growth rate?

Krystal Biotech's revenue growth rate for the last 3 years (2023-2025) was 667.53%, and for the last 5 years (2021-2025) was 0%.